Complement C5 inhibition in patients with COVID-19-a promising target?
Gespeichert in:
| Veröffentlicht in: | Haematologica (Roma) 2020-12, Vol.105 (12), p.2847-2850 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2850 |
|---|---|
| container_issue | 12 |
| container_start_page | 2847 |
| container_title | Haematologica (Roma) |
| container_volume | 105 |
| creator | de Latour, Regis Peffault Bergeron, Anne Lengline, Etienne Dupont, Thibault Marchal, Armance Galicier, Lionel de Castro, Nathalie Bondeelle, Louise Darmon, Michael Dupin, Clairelyne Dumas, Guillaume Leguen, Pierre Madelaine, Isabelle Chevret, Sylvie Molina, Jean-Michel Azoulay, Elie Fremeaux-Bacchi, Veronique |
| description | |
| doi_str_mv | 10.3324/haematol.2020.260117 |
| format | Article |
| fullrecord | <record><control><sourceid>webofscience</sourceid><recordid>TN_cdi_webofscience_primary_000596541600023CitationCount</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>000596541600023</sourcerecordid><originalsourceid>FETCH-webofscience_primary_0005965416000233</originalsourceid><addsrcrecordid>eNqVjsFOAyEYhP8Yjd1W38ADd8P2Bwq7nDygjZ68GK8NbWgXs8BmwTS-vZj4AHqaSebLzADcMWyF4Jv1YF2wJY0tR44tV8hYdwENk5rTvuPsEhoUGqnCrl_AMucPrKDW3TUsaoFUopcNbE0K0-iCi4UYSXwc_N4Xn2K1ZLLF1yCTsy8DMa_vL4-UaWrJNKfgs48nUux8cuXhBq6Odszu9ldXcL99ejPP9Oz26ZgPtebgdtPsg52_dogotZIbpqrjQqyg_zttfLE_B036jEX8b-gbeAVbNQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Complement C5 inhibition in patients with COVID-19-a promising target?</title><source>DOAJ Directory of Open Access Journals</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>PubMed Central</source><creator>de Latour, Regis Peffault ; Bergeron, Anne ; Lengline, Etienne ; Dupont, Thibault ; Marchal, Armance ; Galicier, Lionel ; de Castro, Nathalie ; Bondeelle, Louise ; Darmon, Michael ; Dupin, Clairelyne ; Dumas, Guillaume ; Leguen, Pierre ; Madelaine, Isabelle ; Chevret, Sylvie ; Molina, Jean-Michel ; Azoulay, Elie ; Fremeaux-Bacchi, Veronique</creator><creatorcontrib>de Latour, Regis Peffault ; Bergeron, Anne ; Lengline, Etienne ; Dupont, Thibault ; Marchal, Armance ; Galicier, Lionel ; de Castro, Nathalie ; Bondeelle, Louise ; Darmon, Michael ; Dupin, Clairelyne ; Dumas, Guillaume ; Leguen, Pierre ; Madelaine, Isabelle ; Chevret, Sylvie ; Molina, Jean-Michel ; Azoulay, Elie ; Fremeaux-Bacchi, Veronique ; CORE Grp</creatorcontrib><identifier>ISSN: 0390-6078</identifier><identifier>EISSN: 1592-8721</identifier><identifier>DOI: 10.3324/haematol.2020.260117</identifier><identifier>PMID: 33256385</identifier><identifier>PMID: 32703791</identifier><language>eng</language><publisher>PAVIA: Ferrata Storti Foundation</publisher><subject>Hematology ; Life Sciences & Biomedicine ; Science & Technology</subject><ispartof>Haematologica (Roma), 2020-12, Vol.105 (12), p.2847-2850</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>46</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000596541600023</woscitedreferencesoriginalsourcerecordid><cites>FETCH-webofscience_primary_0005965416000233</cites><orcidid>0000-0001-7957-8195 ; 0000-0003-2156-254X ; 0000-0002-2401-7873</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,866,2116,27931,27932,28255</link.rule.ids></links><search><creatorcontrib>de Latour, Regis Peffault</creatorcontrib><creatorcontrib>Bergeron, Anne</creatorcontrib><creatorcontrib>Lengline, Etienne</creatorcontrib><creatorcontrib>Dupont, Thibault</creatorcontrib><creatorcontrib>Marchal, Armance</creatorcontrib><creatorcontrib>Galicier, Lionel</creatorcontrib><creatorcontrib>de Castro, Nathalie</creatorcontrib><creatorcontrib>Bondeelle, Louise</creatorcontrib><creatorcontrib>Darmon, Michael</creatorcontrib><creatorcontrib>Dupin, Clairelyne</creatorcontrib><creatorcontrib>Dumas, Guillaume</creatorcontrib><creatorcontrib>Leguen, Pierre</creatorcontrib><creatorcontrib>Madelaine, Isabelle</creatorcontrib><creatorcontrib>Chevret, Sylvie</creatorcontrib><creatorcontrib>Molina, Jean-Michel</creatorcontrib><creatorcontrib>Azoulay, Elie</creatorcontrib><creatorcontrib>Fremeaux-Bacchi, Veronique</creatorcontrib><creatorcontrib>CORE Grp</creatorcontrib><title>Complement C5 inhibition in patients with COVID-19-a promising target?</title><title>Haematologica (Roma)</title><addtitle>HAEMATOLOGICA</addtitle><subject>Hematology</subject><subject>Life Sciences & Biomedicine</subject><subject>Science & Technology</subject><issn>0390-6078</issn><issn>1592-8721</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><recordid>eNqVjsFOAyEYhP8Yjd1W38ADd8P2Bwq7nDygjZ68GK8NbWgXs8BmwTS-vZj4AHqaSebLzADcMWyF4Jv1YF2wJY0tR44tV8hYdwENk5rTvuPsEhoUGqnCrl_AMucPrKDW3TUsaoFUopcNbE0K0-iCi4UYSXwc_N4Xn2K1ZLLF1yCTsy8DMa_vL4-UaWrJNKfgs48nUux8cuXhBq6Odszu9ldXcL99ejPP9Oz26ZgPtebgdtPsg52_dogotZIbpqrjQqyg_zttfLE_B036jEX8b-gbeAVbNQ</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>de Latour, Regis Peffault</creator><creator>Bergeron, Anne</creator><creator>Lengline, Etienne</creator><creator>Dupont, Thibault</creator><creator>Marchal, Armance</creator><creator>Galicier, Lionel</creator><creator>de Castro, Nathalie</creator><creator>Bondeelle, Louise</creator><creator>Darmon, Michael</creator><creator>Dupin, Clairelyne</creator><creator>Dumas, Guillaume</creator><creator>Leguen, Pierre</creator><creator>Madelaine, Isabelle</creator><creator>Chevret, Sylvie</creator><creator>Molina, Jean-Michel</creator><creator>Azoulay, Elie</creator><creator>Fremeaux-Bacchi, Veronique</creator><general>Ferrata Storti Foundation</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><orcidid>https://orcid.org/0000-0001-7957-8195</orcidid><orcidid>https://orcid.org/0000-0003-2156-254X</orcidid><orcidid>https://orcid.org/0000-0002-2401-7873</orcidid></search><sort><creationdate>20201201</creationdate><title>Complement C5 inhibition in patients with COVID-19-a promising target?</title><author>de Latour, Regis Peffault ; Bergeron, Anne ; Lengline, Etienne ; Dupont, Thibault ; Marchal, Armance ; Galicier, Lionel ; de Castro, Nathalie ; Bondeelle, Louise ; Darmon, Michael ; Dupin, Clairelyne ; Dumas, Guillaume ; Leguen, Pierre ; Madelaine, Isabelle ; Chevret, Sylvie ; Molina, Jean-Michel ; Azoulay, Elie ; Fremeaux-Bacchi, Veronique</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-webofscience_primary_0005965416000233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Hematology</topic><topic>Life Sciences & Biomedicine</topic><topic>Science & Technology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Latour, Regis Peffault</creatorcontrib><creatorcontrib>Bergeron, Anne</creatorcontrib><creatorcontrib>Lengline, Etienne</creatorcontrib><creatorcontrib>Dupont, Thibault</creatorcontrib><creatorcontrib>Marchal, Armance</creatorcontrib><creatorcontrib>Galicier, Lionel</creatorcontrib><creatorcontrib>de Castro, Nathalie</creatorcontrib><creatorcontrib>Bondeelle, Louise</creatorcontrib><creatorcontrib>Darmon, Michael</creatorcontrib><creatorcontrib>Dupin, Clairelyne</creatorcontrib><creatorcontrib>Dumas, Guillaume</creatorcontrib><creatorcontrib>Leguen, Pierre</creatorcontrib><creatorcontrib>Madelaine, Isabelle</creatorcontrib><creatorcontrib>Chevret, Sylvie</creatorcontrib><creatorcontrib>Molina, Jean-Michel</creatorcontrib><creatorcontrib>Azoulay, Elie</creatorcontrib><creatorcontrib>Fremeaux-Bacchi, Veronique</creatorcontrib><creatorcontrib>CORE Grp</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><jtitle>Haematologica (Roma)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Latour, Regis Peffault</au><au>Bergeron, Anne</au><au>Lengline, Etienne</au><au>Dupont, Thibault</au><au>Marchal, Armance</au><au>Galicier, Lionel</au><au>de Castro, Nathalie</au><au>Bondeelle, Louise</au><au>Darmon, Michael</au><au>Dupin, Clairelyne</au><au>Dumas, Guillaume</au><au>Leguen, Pierre</au><au>Madelaine, Isabelle</au><au>Chevret, Sylvie</au><au>Molina, Jean-Michel</au><au>Azoulay, Elie</au><au>Fremeaux-Bacchi, Veronique</au><aucorp>CORE Grp</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complement C5 inhibition in patients with COVID-19-a promising target?</atitle><jtitle>Haematologica (Roma)</jtitle><stitle>HAEMATOLOGICA</stitle><date>2020-12-01</date><risdate>2020</risdate><volume>105</volume><issue>12</issue><spage>2847</spage><epage>2850</epage><pages>2847-2850</pages><issn>0390-6078</issn><eissn>1592-8721</eissn><cop>PAVIA</cop><pub>Ferrata Storti Foundation</pub><pmid>33256385</pmid><pmid>32703791</pmid><doi>10.3324/haematol.2020.260117</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-7957-8195</orcidid><orcidid>https://orcid.org/0000-0003-2156-254X</orcidid><orcidid>https://orcid.org/0000-0002-2401-7873</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0390-6078 |
| ispartof | Haematologica (Roma), 2020-12, Vol.105 (12), p.2847-2850 |
| issn | 0390-6078 1592-8721 |
| language | eng |
| recordid | cdi_webofscience_primary_000596541600023CitationCount |
| source | DOAJ Directory of Open Access Journals; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; PubMed Central |
| subjects | Hematology Life Sciences & Biomedicine Science & Technology |
| title | Complement C5 inhibition in patients with COVID-19-a promising target? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T05%3A32%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-webofscience&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complement%20C5%20inhibition%20in%20patients%20with%20COVID-19-a%20promising%20target?&rft.jtitle=Haematologica%20(Roma)&rft.au=de%20Latour,%20Regis%20Peffault&rft.aucorp=CORE%20Grp&rft.date=2020-12-01&rft.volume=105&rft.issue=12&rft.spage=2847&rft.epage=2850&rft.pages=2847-2850&rft.issn=0390-6078&rft.eissn=1592-8721&rft_id=info:doi/10.3324/haematol.2020.260117&rft_dat=%3Cwebofscience%3E000596541600023%3C/webofscience%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33256385&rfr_iscdi=true |